The government also plans to quickly reclassify marijuana broadly, a potential boon for companies that sell for recreational use and have contended with a weak consumer spending climate and competition from illegal sellers. File.
| Photo Credit: Reuters
Companies developing cannabis-based medicines say U.S. moves to loosen restrictions on the drug could unlock private funding and the public markets, providing a lifeline to the struggling cannabis industry.
The U.S. Department of Justice last week rescheduled FDA-approved medicines and state-regulated medical marijuana products, making it easier for companies to bank and receive tax credits and deductions.
Published – May 01, 2026 10:59 am IST
